Nuclear Medicine Market Size, Share & Industry Analysis, By Type (Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, and Others] and SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, and Others]} and Therapeutics {Ra-223, Sm-153, Lu-177, I-131, Y-90, and Others}), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI101812

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Installed Base of PET/PET CT Scanners (Estimated), By Key Countries, 2025
2. Installed Base of Gamma Cameras (Estimated), By Key Countries, 2025
3. PET/PET CT Procedure Volume (Estimated), By Key Countries, 2025
4. Pipeline Analysis, By Key Players
5. Overview: Ga-68 Demand
6. Overview: Radioisotope Generators, Current & Future Trends
7. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
8. Impact of COVID-19 on the Market
9. Regulatory Overview: Key Countries/ Region
10. Brief Profiles of Key Manufacturers, Cyclotrons
11. Supply Chain Analysis: Radioisotopes
Global Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
7.1.2.4.I-131
1. 1. 1. Y-90
    2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
10.1.2.4.I-131
1. 1. 1. Y-90
    2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GE HealthCare
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Lantheus Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Nordion (Canada) Inc. (Sotera Health)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Bracco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Curium
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Bayer AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Siemens Healthineers AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Jubilant Pharmova Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Cardinal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Norgine
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  12. DuchemBio, Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Market Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Installed Base of PET/PET CT Scanners (Estimated), By Key Countries, 2025
2. Installed Base of Gamma Cameras (Estimated), By Key Countries, 2025
3. PET/PET CT Procedure Volume (Estimated), By Key Countries, 2025
4. Pipeline Analysis, By Key Players
5. Overview: Ga-68 Demand
6. Overview: Radioisotope Generators, Current & Future Trends
7. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
8. Impact of COVID-19 on the Market
9. Regulatory Overview: Key Countries/ Region
10. Brief Profiles of Key Manufacturers, Cyclotrons
11. Supply Chain Analysis: Radioisotopes
Global Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
7.1.2.4.I-131
1. 1. 1. Y-90
    2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
    4. I-131
    5. Y-90
    6. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Nuclear Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic
    1. Ra-223
    2. Sm-153
    3. Lu-177
10.1.2.4.I-131
1. 1. 1. Y-90
    2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GE HealthCare
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Lantheus Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Nordion (Canada) Inc. (Sotera Health)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Bracco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Curium
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Bayer AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Siemens Healthineers AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Jubilant Pharmova Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Cardinal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Norgine
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  12. DuchemBio, Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Nuclear Medicine Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Nuclear Medicine Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Nuclear Medicine Market Value Share (%), by Application, 2025 & 2034

Figure 4: Global Nuclear Medicine Market Value Share (%), by End-user, 2025 & 2034

Figure 5: Global Nuclear Medicine Market Value (USD billion), by Region, 2025 & 2034

Figure 6: North America Nuclear Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 7: North America Nuclear Medicine Market Value (USD billion), by Application, 2025 & 2034

Figure 8: North America Nuclear Medicine Market Value (USD billion), by End-user, 2025 & 2034

Figure 9: North America Nuclear Medicine Market Value (USD billion), By Country, 2025 & 2034

Figure 10: Europe Nuclear Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 11: Europe Nuclear Medicine Market Value (USD billion), by Application, 2025 & 2034

Figure 12: Europe Nuclear Medicine Market Value (USD billion), by End-user, 2025 & 2034

Figure 13: Europe Nuclear Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 14: Asia Pacific Nuclear Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 15: Asia Pacific Nuclear Medicine Market Value (USD billion), by Application, 2025 & 2034

Figure 16: Asia Pacific Nuclear Medicine Market Value (USD billion), by End-user, 2025 & 2034

Figure 17: Asia Pacific Nuclear Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 18: Latin America Nuclear Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 19: Latin America Nuclear Medicine Market Value (USD billion), by Application, 2025 & 2034

Figure 20: Latin America Nuclear Medicine Market Value (USD billion), by End-user, 2025 & 2034

Figure 21: Latin America Nuclear Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 22: Middle East & Africa Nuclear Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 23: Middle East & Africa Nuclear Medicine Market Value (USD billion), by Application, 2025 & 2034

Figure 24: Middle East & Africa Nuclear Medicine Market Value (USD billion), by End-user, 2025 & 2034

Figure 25: Middle East & Africa Nuclear Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26: Global Nuclear Medicine Market Share (%), By Company, 2025

List of Tables

Table 1: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 2: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 3: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 4: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 5: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 6: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 7: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 8: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 9: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 10: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 11: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 12: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 13: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 14: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 15: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 16: North America Nuclear Medicine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 17: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 18: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 19: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 20: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 21: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 22: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 23: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 24: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 25: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 26: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 27: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 28: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 29: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 30: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 31: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 32: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 33: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 34: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 35: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 36: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 37: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 38: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 39: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 40: Latin America Nuclear Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 41: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 42: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 43: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2021-2034

Table 44: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2021-2034

Table 45: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 46: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 47: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 48: Middle East & Africa Nuclear Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Nuclear Medicine/ Radiopharmaceuticals Market

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 246

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com